Titan Medical : to Present at Bloom Burton Healthcare Investor Conference; Company to Report First Quarter 2016 Financial Results

TORONTO, ON — (Marketwired) — 04/29/16 — Titan Medical Inc. (TSX: TMD)(OTCQX: TITXF), a medical device company focused on the design and development of the SPORT™ Robotic Surgical System for application in minimally invasive surgery (MIS), today announced thatJohn Hargrove, Chairman and CEO, and Dennis Fowler, EVP, Clinical and Regulatory Affairs, will present at the 2016 Bloom Burton & Co.Healthcare Investor Conference at the Sheraton Centre Toronto Hotelon Monday, May 2, 2016 at 10:00 a.m. Eastern Time.

To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company’s website at

For more information about the conference, please go to

First Quarter 2016 Conference Call and Webcast

Titan Medical also announced today that it will release its financial results for the 2016 first quarter ended March 31, 2016 after market close on Monday, May 16, 2016.

Titan management will host a conference call beginning at 5:00 p.m. ET on May 16 to discuss the results, provide an update on recent progress and to answer investor questions. To access the live call by telephone, dial 800-499-4035 (US and Canada) or +1 416-204-9269 (International) and reference the Conference ID: 2116944.

A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company’s website under “Events & Presentations” at To listen to the live webcast, please go to the website 15-minutes prior to its start to register, download and install the necessary audio software.

A phone replay of the call will be available approximately two hours following the end of the call through 8:00 p.m. ET on Monday, May 23, 2016. To access the replay numbers, please visit and use passcode 2116944.

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”). The Company’s SPORT™ Surgical System, currently under development, includes a surgeon-controlled robotic platform that incorporates a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures through a single incision. The surgical system also includes a surgeon workstation that provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and provides a 3D high-definition endoscopic view of inside a patient’s body. The SPORT™ Surgical System is designed to enable surgeons to perform a broad set of surgical procedures for general abdominal, gynecologic, and urologic indications. For more information, visit the Company’s website at

Forward-Looking Statements

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the Company’s Annual Information Form dated March 30, 2016 (which may be viewed at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

Source: Titan Medical Inc.

© Marketwire, source Press Releases


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button